Insulet Corporation (PODD): Price and Financial Metrics


Insulet Corporation (PODD): $290.60

2.60 (+0.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PODD POWR Grades


  • PODD scores best on the Growth dimension, with a Growth rank ahead of 79.88% of US stocks.
  • PODD's strongest trending metric is Quality; it's been moving down over the last 48 weeks.
  • PODD ranks lowest in Momentum; there it ranks in the 15th percentile.

PODD Stock Summary

  • With a one year PEG ratio of 955.05, Insulet Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.83% of US stocks.
  • The price/operating cash flow metric for Insulet Corp is higher than 99.23% of stocks in our set with a positive cash flow.
  • With a price/sales ratio of 19.92, Insulet Corp has a higher such ratio than 90.34% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Insulet Corp, a group of peers worth examining would be SPT, UPWK, BAND, JAMF, and VRNT.
  • PODD's SEC filings can be seen here. And to visit Insulet Corp's official web site, go to www.insulet.com.

PODD Valuation Summary

  • PODD's price/earnings ratio is -672.5; this is 1942.47% lower than that of the median Healthcare stock.
  • Over the past 174 months, PODD's price/sales ratio has gone down 86.7.
  • PODD's EV/EBIT ratio has moved up 1031.5 over the prior 174 months.

Below are key valuation metrics over time for PODD.

Stock Date P/S P/B P/E EV/EBIT
PODD 2021-08-31 20.6 44.7 -672.5 1020.1
PODD 2021-08-30 20.5 44.4 -668.8 1014.6
PODD 2021-08-27 20.4 44.3 -666.4 1011.0
PODD 2021-08-26 20.3 44.1 -664.2 1007.8
PODD 2021-08-25 20.7 45.0 -676.9 1026.7
PODD 2021-08-24 20.8 45.0 -677.5 1027.6

PODD Growth Metrics

  • Its 5 year net cashflow from operations growth rate is now at 730.36%.
  • Its year over year net cashflow from operations growth rate is now at -40.63%.
  • The 3 year net cashflow from operations growth rate now stands at 337.64%.
Over the past 70 months, PODD's revenue has gone up $698,933,000.

The table below shows PODD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 995.6 44.4 -30.5
2021-03-31 958.7 52.5 8.9
2020-12-31 904.4 84 6.8
2020-09-30 867.694 131.933 28.868
2020-06-30 825.809 100.923 18.12
2020-03-31 776.645 88.433 5.122

PODD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PODD has a Quality Grade of C, ranking ahead of 60.18% of graded US stocks.
  • PODD's asset turnover comes in at 0.542 -- ranking 87th of 183 Medical Equipment stocks.
  • UFPT, NEPH, and NSPR are the stocks whose asset turnover ratios are most correlated with PODD.

The table below shows PODD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.542 0.666 0.011
2021-03-31 0.544 0.650 0.036
2020-12-31 0.573 0.644 0.034
2020-09-30 0.621 0.640 0.049
2020-06-30 0.642 0.638 0.040
2020-03-31 0.691 0.644 0.029

PODD Price Target

For more insight on analysts targets of PODD, see our PODD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $290.41 Average Broker Recommendation 1.6 (Moderate Buy)

PODD Stock Price Chart Interactive Chart >

Price chart for PODD

PODD Price/Volume Stats

Current price $290.60 52-week high $309.99
Prev. close $288.00 52-week low $213.51
Day low $286.45 Volume 219,737
Day high $291.41 Avg. volume 454,863
50-day MA $286.79 Dividend yield N/A
200-day MA $272.60 Market Cap 20.01B

Insulet Corporation (PODD) Company Bio


Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company was founded in 2000 and is based in Billerica, Massachusetts.


PODD Latest News Stream


Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream


Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about Insulet Corp that investors may wish to consider to help them evaluate PODD as an investment opportunity.

Wearable Injectors Market 2021 Is Thriving Worldwide: Amgen, Subcuject, Enable Injections, Medtronic Plc, Insulet Corporation, United Therapeutics Corp, CeQur SA

Wearable Injectors Market report provides a profound overview of product specification, technology, product type, and production analysis considering major factors such as revenue, cost, and gross margin. Competitor analysis is one of the most important aspects of a market research

OpenPR | September 21, 2021

5 Top Stocks for September

If the September Effect hits us again this year, our contributors have five stocks to suggest that you could pick up at a discount: Insulet (NASDAQ: PODD), Amazon (NASDAQ: AMZN), Shopify (NYSE: SHOP), Cresco Labs (OTC: CRLBF), and PubMatic (NASDAQ: PUBM). Medtronic and Tandem Diabetes were the first companies to offer next-generation, automated insulin delivery systems, but stiff competition from Insulet's Omnipod 5 could be coming soon.

Yahoo | September 11, 2021

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi''s Pemphigus Trial Disappointment, Humanigen''s COVID-19 Drug Denied Emergency Use Authorization

Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE: ABT ) Candel Therapeutics, Inc. (NASDAQ: CADL ) (announced its quarterly results) Cardiol Therapeutics Inc. (NASDAQ: CRDL ) Catalent, Inc. (NASDAQ: CTLT ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) DexCom, Inc. (NASDAQ: DXCM ) Edwards Lifesciences Corporation (NYSE: EW ) ICU Medical, Inc. (NASDAQ: ICUI ) (announced a deal to buy Smiths Medical division for $2.35 billion in cash) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Kadmon Holdings, Inc. (NASDAQ: KDMN ) - announced a deal to be bought by S...

Benzinga | September 9, 2021

Medication Telemanagement Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 | Abiogenix, Adherium, IA Collaborative, Insulet, MedFolio, Medissimo, MedMinder, MedSignals

The Medication Telemanagement Devices Market report describes in detail the demand and consumption of various products/services related to the market growth dynamics during the forecast period of 2021-2027. A detailed market assessment of the various opportunities in the market segment

OpenPR | September 8, 2021

The Daily Biotech Pulse: MacroGenics'' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA''s FDA Nod

Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Candel Therapeutics, Inc. (NASDAQ: CADL ) (announced completion of patient enrollment in the pivotal phase 3 study of CAN-2409 in prostate cancer) Cardiol Therapeutics Inc. (NASDAQ: CRDL ) (announced addition to its board) Caribou Biosciences, Inc. (NASDAQ: CRBU ) Catalent, Inc. (NASDAQ: CTLT ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN ) Edwards Lifesciences Corporation (NYSE: EW ) Er...

Benzinga | September 8, 2021

Read More 'PODD' Stories Here

PODD Price Returns

1-mo -3.14%
3-mo 4.40%
6-mo 8.92%
1-year 27.65%
3-year 183.24%
5-year 561.51%
YTD 13.68%
2020 49.32%
2019 115.83%
2018 14.96%
2017 83.12%
2016 -0.34%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8918 seconds.